Literature DB >> 29162349

Agreement between parents and clinicians on the communication function levels and relationship of classification systems of children with cerebral palsy.

Akmer Mutlu1, Özgün Kaya Kara2, Ayşe Livanelioğlu3, Sevilay Karahan4, Halil Alkan5, Bilge Nur Yardımcı6, Mary Jo Cooley Hidecker7.   

Abstract

BACKGROUND: Functional classification systems have generally been used by clinicians and recently by parents to classify various functions of children with cerebral palsy (CP).
OBJECTIVE: This study evaluated the agreement between clinicians and parents when classifying the communication function of children with CP using the Communication Function Classification System (CFCS). In addition, the relationships between the Gross Motor Function Classification System - Expanded and Revised (GMFCS-E&R), the Manual Ability Classification System (MACS), and CFCS were investigated.
METHODS: This study was a cross-sectional study and included 102 children aged 4-18 years with CP and their parents. The parents and clinician classified the communication of children by using the Turkish language version of CFCS. Furthermore GMFCS-E&R and MACS were used for classification only by the clinician.
RESULTS: The weighted Kappa agreement between CFCS results of the parents and clinicians was 0.95 (95% CI 0.95-0.96, p < 0.001). GMFCS-E&R levels were highly correlated with CFCS levels (r = 0.78 (95%CI 0.68-0.84, p < 0.001)). MACS and CFCS results were also highly correlated (r = 0.73 (95%CI 0.63-0.81, p < 0.001).
CONCLUSION: The child's communication was classified as indicating higher functioning by the parents compared with the clinicians. The excellent agreement between parents and clinicians with the Turkish language version of CFCS for children with CP indicated that parents and clinicians could use the same language while classifying the communication function of children.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Agreement; Cerebral palsy; Communication; Functional classification systems; Parents

Mesh:

Year:  2017        PMID: 29162349     DOI: 10.1016/j.dhjo.2017.11.001

Source DB:  PubMed          Journal:  Disabil Health J        ISSN: 1876-7583            Impact factor:   2.554


  5 in total

1.  Parent-Reported PEDI-CAT Mobility and Gross Motor Function in Infants With Cerebral Palsy.

Authors:  Kimberley Scott; Jessica Lewis; Xueliang Pan; Jill Heathcock
Journal:  Pediatr Phys Ther       Date:  2021-07-01       Impact factor: 1.452

2.  Preschool HABIT-ILE: study protocol for a randomised controlled trial to determine efficacy of intensive rehabilitation compared with usual care to improve motor skills of children, aged 2-5 years, with bilateral cerebral palsy.

Authors:  Leanne Sakzewski; Sarah Reedman; Kate McLeod; Megan Thorley; Andrea Burgess; Stewart Trost; Matthew Ahmadi; David Rowell; Mark Chatfield; Yannick Bleyenheuft; Roslyn N Boyd
Journal:  BMJ Open       Date:  2021-03-02       Impact factor: 2.692

3.  Estimation of Gross Motor Functions in Children with Cerebral Palsy Using Zebris FDM-T Treadmill.

Authors:  Mariusz Bedla; Paweł Pięta; Daniel Kaczmarski; Stanisław Deniziak
Journal:  J Clin Med       Date:  2022-02-12       Impact factor: 4.241

4.  Prediction of Communication Impairment in Children With Bilateral Cerebral Palsy Using Multivariate Lesion- and Connectome-Based Approaches: Protocol for a Multicenter Prospective Cohort Study.

Authors:  Jie Hu; Jingjing Zhang; Yanli Yang; Ting Liang; Tingting Huang; Cheng He; Fuqin Wang; Heng Liu; Tijiang Zhang
Journal:  Front Hum Neurosci       Date:  2022-01-31       Impact factor: 3.169

5.  Protocol for a multisite randomised trial of Hand-Arm Bimanual Intensive Training Including Lower Extremity training for children with bilateral cerebral palsy: HABIT-ILE Australia.

Authors:  Leanne Sakzewski; Yannick Bleyenheuft; Roslyn N Boyd; Iona Novak; Catherine Elliott; Sarah Reedman; Cathy Morgan; Kerstin Pannek; Jurgen Fripp; Prue Golland; David Rowell; Mark Chatfield; Robert Stuart Ware
Journal:  BMJ Open       Date:  2019-09-08       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.